[GBSN] Great Basin Scientific, Inc.
Overview
Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Strongest Trends Summary For GBSN
GBSN is in the long-term down -100% below S&P in 5 years.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Great Basin Scientific, Inc., a molecular diagnostics company, develops and manufactures test kits and analyzers for a patented molecular diagnostic system used in single pathogen tests. The company provides a medical diagnostic test for the detection of Clostridium difficile, a gram-positive bacteria that causes diarrhea and other intestinal disorders. Its products under development comprise a diagnostic test for Group B streptococcus, a bacterium that colonizes in the warm moist areas of various humans, as well as a test for blood infections caused by Staphylococcus bacteria, a pre-surgical nasal screen for Staphylococcus aureus, and a food borne pathogen test. The company sells its diagnostic tests through a direct sales force in the United States, as well as through distributors in the European Union and New Zealand. The company was formerly known as Diagnostic Micro Arrays, Inc. and changed its name to Great Basin Scientific, Inc. in April 2006. Great Basin Scientific, Inc. is headquartered in Salt Lake
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | 1076.92% | Sales Growth - Q/Q | 3.15% | P/E | ||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | -353.59% | ROE | 119.12% | ROI | ||
| Current Ratio | 4.25 | Quick Ratio | 4.16 | Long Term Debt/Equity | 5.99 | Debt Ratio | -0.07 |
| Gross Margin | -184.76% | Operating Margin | -1277.22% | Net Profit Margin | -6966.72% | Dividend Payout Ratio | |
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | 22.32 M | Cash From Investing Activities | -160 K | Cash From Operating Activities | -3.59 M | Gross Profit | -510 K |
| Net Profit | -71.17 M | Operating Profit | -3.88 M | Total Assets | 26.64 M | Total Current Assets | 21.94 M |
| Total Current Liabilities | 5.16 M | Total Debt | 3.71 M | Total Liabilities | 105.71 M | Total Revenue | 460 K |
Technical Data
| High 52 week | 14 | Low 52 week | 0.05 | Last close | 0.11 | Last change | -5.01% |
| RSI | 31.54 | Average true range | 0.01 | Beta | 0.58 | Volume | 19.32 M |
| Simple moving average 20 days | -8.82% | Simple moving average 50 days | -11.78% | Simple moving average 200 days | -39.72% |
Performance Data
| Performance Week | -8.33% | Performance Month | -12.97% | Performance Quart | -8.86% | Performance Half | 69.23% |
| Performance Year | -97.25% | Performance Year-to-date | -10.93% | Volatility daily | 3.8% | Volatility weekly | 8.5% |
| Volatility monthly | 17.43% | Volatility yearly | 60.37% | Relative Volume | 466.83% | Average Volume | 118.71 K |
| New High | New Low | -0% |
News
2017-07-18 09:00:00 | SeeThruEquity Issues Update on Great Basin Scientific GBSN on FDA Clearance
2017-07-13 07:00:00 | Great Basin Scientific Receives FDA 510k Clearance for Stool Bacterial Pathogens Panel
2017-07-05 09:00:00 | SeeThruEquity Issues Update on Great Basin Scientific GBSN
2017-06-26 07:00:00 | Great Basin Scientific Provides Business Update
2017-06-22 07:00:00 | Great Basin Scientific Closes $2.7 Million Offering of Units
2017-06-20 09:28:56 | Great Basin Scientific Prices $2.7 Million Registered Offering of Units
2017-06-02 09:58:07 | Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
2017-06-01 07:00:00 | Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin’s Stool Bacterial Pathogens Panel
2017-05-24 07:00:00 | Great Basin Scientific Issued Second U.S. Patent for PCR Amplification Suppressor
2017-05-22 07:00:00 | Great Basin Scientific Reports First Quarter 2017 Results
2017-05-16 07:00:00 | Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
2017-05-15 07:00:00 | Great Basin Scientific Obtains Release of $1.36 Million of Restricted Cash from Series B Convertible Notes
2017-05-08 15:21:46 | Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: Q4, 2016 By the Numbers : May 8, 2017
2017-05-08 13:12:10 | Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: 2016 By the Numbers : May 8, 2017
2017-05-05 07:00:00 | Great Basin Scientific Stock Symbol Reverts to GBSN
2017-04-12 07:00:00 | Great Basin Scientific Receives CE Marking for Stool Bacterial Pathogens Panel
2017-04-10 09:08:38 | Great Basin Scientific Announces Restructuring of Convertible Securities
2017-04-07 16:01:00 | Great Basin Scientific Announces Date of Effectiveness of Reverse Stock Split
2017-04-07 08:30:00 | Great Basin What's Next in the Pipeline Following FDA Clearance for Bordetella Direct Test
2017-04-06 07:30:00 | Study Published in PLOS ONE Demonstrates Effectiveness of Great Basin Scientific’s Patented Amplification Suppressor Technology
2017-04-03 16:00:00 | Great Basin Scientific Receives FDA 510k Clearance for Bordetella Direct Test
2017-03-22 07:03:23 | Great Basin Scientific Reports Fourth Quarter and Full Year 2016 Results
2017-03-22 07:01:46 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
2017-03-10 07:17:42 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD D
2017-03-09 20:55:14 | Great Basin Scientific Receives Stockholder Approval for Reverse Stock Split and Authorized Share Increase During Special Meeting
2017-03-03 16:54:10 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ
2017-03-02 07:30:00 | Great Basin Scientific’s Suzette Chance Named a 2017 Woman Worth Watching in STEM by Profiles in Diversity Journal
2017-03-02 06:39:17 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to
2017-02-24 17:17:15 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rig
2017-02-17 06:06:31 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Material Modification
2017-02-16 17:15:38 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to
2017-02-15 07:30:00 | Great Basin Scientific’s Staph ID/R Blood Culture Panel Clinical Evaluation and Rapid Identification Analysis Published in Journal of Clinical Microbiology
2017-02-14 08:45:00 | Great Basin Scientific Announces Filing of Registration Statement on Form S-1
2017-02-14 08:39:58 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
2017-02-10 09:17:06 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Regulation FD Dis
2017-02-10 09:00:00 | Great Basin Scientific Announces Corporate Restructuring and Reduction in Principal of 2016 Convertible Note
2017-02-03 17:12:07 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rig
2017-02-03 07:00:00 | Great Basin Scientific’s Shiga Toxin Direct Test Clinical Evaluation and Cost Analysis Published in Journal of Clinical Microbiology
2017-02-02 08:18:21 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Other Events
2017-02-01 07:00:00 | Great Basin Scientific Completes Clinical Trial, Submits FDA 510k Application for Bordetella Direct Test
2017-01-31 08:59:01 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to
2017-01-26 07:30:00 | Great Basin Scientific Stock Symbol Reverts to GBSN
2017-01-26 06:06:37 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rig
2017-01-24 09:26:04 | Great Basin Scientific Announces Preliminary Fourth Quarter 2016 Revenue
2017-01-20 08:30:00 | Great Basin Announces Request to Withdraw S-1 Registration Statement and Amendment to $75 Million 2016 Convertible Note
2016-12-28 11:17:09 | Great Basin Scientific Stock Symbol Temporarily Changed to GBSND
2016-12-28 07:30:00 | Great Basin Announces Effectiveness of Reverse Stock Split of Common Stock and Authorized Share Increase
2016-12-23 06:03:49 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to A
2016-12-22 18:45:09 | Great Basin Scientific Shareholders Approve Reverse Stock Split and Authorized Share Increase During Special Meeting
2016-12-19 07:30:00 | Great Basin Scientific Submits 510k Application to the FDA for Stool Bacterial Pathogens Panel